Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × ABX464 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colitis, Ulcerative 1

Interventions

pembrolizumab 239 Nivolumab 153 Cyclophosphamide 137 Cisplatin 128 Paclitaxel 117 Carboplatin 114 Gemcitabine 98 Radiotherapy 91 Dexamethasone 90 Ipilimumab 76 Docetaxel 73 atezolizumab 66 Fluorouracil 65 Blood Specimen Collection 62 Lenalidomide 58 Rituximab 57 Doxorubicin 57 Prednisone 55 fludarabine 54 Bevacizumab 53 Oxaliplatin 52 Standard of Care 49 Etoposide 48 durvalumab 46 Cetuximab 46 Surveys and Questionnaires 45 Trastuzumab 44 lenvatinib 43 Capecitabine 43 Cytarabine 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Abivax S.A.

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡